Inhibition of HDAC in human prostate cancer cell lines using suberoylanilide hydroxamic acid (SAHA).Inhibition of HDAC in radioresistant esophageal carcinoma cells lines using trichostatin A and sodium butyrate. Here, HDAC9 is linked to prostate cancer.